GlassScriptPhysician profile
Sheila E Weaver
NPI 1831187970
$1,038.55
in general payments reported to CMS, 2019-2025
10 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.06 · 2021: $111 · 2022: $210 · 2023: $230 · 2024: $274 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.07 |
| Education | $151.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $562.52 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $197.38 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $90.00 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $66.50 | 2021 | |
| Merck Sharp & Dohme LLC | $61.88 | 2024-2025 | Winrevair |
| Endovascular Engineering INC. | $43.55 | 2025 | Helo Thrombectomy System |
| Resmed Corp | $16.72 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.